Loading...

MAZE MAZE THERAPEUTICS INC Management Changes 8-K Filing

MZ T

MZ

MAZE THERAPEUTICS INC

(MAZE)

2026 8-K

Financial Results Report

Stock Offering Announcement

Director Appointment

Loan Agreement Details

Financial Results Released

Board Appointment

Equity Sale Announcement

Management Change

Financial Statements

Financial Results

External Links:

Maze Therapeutics, Inc. appointed Neil Kumar as a Class I director effective March 27, 2026, with a compensation package including an option to purchase up to 36,000 shares of common stock.

AI Assistant

MAZE THERAPEUTICS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.